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FIGURE 2. Trichrome staining of the aortic aneurysm shows red blood
cell infiltration of the aortic wall. Colonies of gram-positive cocci are
stained red. (Original magnification, 203.)
Brief Clinical Reportsof a low rate of reinfection, durability, and potential for
growth.3 There is concern that if the autograft were to be-
come infected, then the optimal valve for the long-term
might be wasted. An alternative would be to use an aortic
homograft in what amounts to a palliative first stage of
a 2-stage approach. Although offering all of the advantages
of a stentless bioprosthesis, the durability of aortic homo-
grafts has been very limited in infants and young children.4
Use of a homograft would be directed at eliminating the risk
of autograft reinfection, saving that valve for later implanta-
tion when infection has cleared and homograft replacement
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The Journal of Thoracic and CaA confounding problem is the presence of ascending aor-
titis in conjunction with aortic valve endocarditis. This
highly unusual condition requires replacement of the entire
ascending aorta and thus complicates a Ross procedure
because the pulmonary autograft would require prosthetic
extension. Such an extension might increase the risk of rein-
fection, severely limit the durability of the Ross repair by vir-
tue of a lack of growth potential, or both. Hence the aortic
homograft becomes the best choice, with expectation that
the Ross procedure would be performed at time of homograft
failure. We predicted that the homograft would last 1 year or
less based on prior experience. The primary concern for use
of an autograft at the initial procedure was infection that
might compromise the best long-term valve replacement op-
tion for this infant.Many of our pediatric patients undergoing
the Ross procedure have had previous operations, including
an aortic root replacement, and risk of reoperation in this pop-
ulation has been low. Aortic homograft implantation has
been reported in the setting of acute aortitis in 2 children.5References
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Abiotrophia defectiva endocarditis. Pediatr Infect Dis J. 2004;23:574-6.An unusual tumor of the esophagusGeorge Rakovich, MD, Denise Ouellette, MD, and Gilles Beauchamp, MD, Montreal, Quebec, CanadaCarcinosarcoma of the esophagus is a very rare tumor that
has both epithelial and mesenchymal (sarcomatous) compo-
nents. The points of interest in the presented case are theosteosarcomatous nature of the mesenchymal component,
as well as the early and massive recurrence after esophagec-
tomy despite an early pathologic stage, reflecting the fast-
growing and potentially aggressive nature of these tumors.
CLINICAL SUMMARY
A 70-year-old man presented with progressive dysphagia
to solid food, which he localized at the level of the mideso-
phagus. He was an active smoker with a professional expo-
sure to asbestos over a period of 25 years, and his medical
history included hypercholesterolemia and a T3 N0 prostate
cancer currently in remission after radiotherapy. Initially, he
had had an acute episode of chest pain immediately afterrdiovascular Surgery c Volume 139, Number 4 e91
FIGURE 1. Endoscopic image showing a bulky esophageal tumor.
FIGURE 2. Biopsy specimen of the esophageal tumor revealing a mixed
population of malignant squamous cells (white arrow) and osteosarcoma-
tous cells (black arrow).
FIGURE 3. Computed tomographic image showing massive mediastinal
recurrence containing calcifications caused by the osteosarcomatous com-
ponent of the tumor.
Brief Clinical Reportsa meal at a Chinese restaurant; although he still described
some mild pain on swallowing, this was not a predominant
symptom. There were no symptoms suggestive of gastro-
esophageal reflux disease. Results of physical examination
and routine blood work were normal.
Barium swallow showed a large 7 3 4–cm mass in the
middle third of the esophagus that did not impede the
passage of contrast medium. Endoscopy showed a very
large, friable, and partially ulcerated mass in the mideso-
phagus that allowed passage of the endoscope (Figure 1).
The lesion was also visible on computed tomographic
analysis as a bulky, homogenous soft tissue mass distend-
ing the esophageal lumen. There were no suspicious
lymph nodes or distant metastases. The lesion had
a mean standard uptake value of 19.7 on positron
emission tomographic analysis. Endoscopic biopsy spec-
imens showed a carcinosarcoma consisting of 2 compo-
nents: malignant squamous and osteosarcomatous cells
(Figure 2).
The patient underwent a standard 3-field esophagectomy
and lymphadenectomywith gastric replacement and cervical
anastomosis. A small anastomotic fistula healed with local
measures, and the patient was discharged 1 month postoper-
atively in good condition. On histologic analysis of the op-
erative specimen, the tumor infiltrated the submucosa, and
there was 1 metastatic periesophageal lymph node (final
stage T1 N1 M0).
Four months postoperatively, the patient presented with
progressive weakness and a large nodule in his laparotomy
scar. Fine-needle aspiration revealed neoplastic cells. Repeat
computed tomographic scanning showed a massive intratho-
racic and intra-abdominal recurrence. The entire lumen of
the gastric transplant was obstructed by a tumor that
extended into the mediastinum; there were multiple pleuro-
pulmonary and peritoneal implants, hepatic metastases, ande92 The Journal of Thoracic and Cardiovascular Surgcalcified tumor within the laparotomy scar, as noted on phys-
ical examination. The metastases contained areas of calcifi-
cation that were consistent with the osteosarcomatous
component of the tumor (Figure 3). The patient died within
a few weeks.DISCUSSION
Carcinosarcoma of the esophagus is rare and represents
less than 2% of esophageal tumors.1 It tends to occur pre-
dominantly in middle-aged men with a history of tobacco
and alcohol use.2,3 Although the term pseudosarcoma has
previously been reserved for tumors in which an underly-
ing epithelial malignancy is apparently associated with
a benign mesenchymal reaction, it has become apparent
that both cell populations can metastasize, and thus the
term carcinosarcoma is generally used when malignant
cells of both epithelial and mesenchymal origin coexistery c April 2010
Brief Clinical Reportswithin the same tumor.2 It is generally accepted that these
tumors originate as a primary epithelial malignancy from
which a subset of cells then undergoes dedifferentiation
into sarcomatous cells.1,2 This theory is supported by the
frequent finding of a transition zone between the 2 cell
populations.2,4 Previous theories of 2 simultaneously
occurring malignancies (collision tumor) or a common
origin from a single pleomorphic cell population have
fallen out of favor.2
The epithelial component is usually squamous cell carci-
noma, but adenocarcinoma can also occur.4 Fibrosarcoma is
the most common sarcomatous component, although rhab-
domyosarcoma, chondrosarcoma, and osteosarcoma (as oc-
curred in our patient) have also been described.2,4 The
sarcomatous cells stain for vimentin, whereas the epithelial
cells stain for cytokeratin,4 although it has been reported
that the sarcomatous cells might stain for cytokeratin and
the epithelial cells for vimentin.4 Importantly, results of S-
100 protein staining are negative, thus differentiating carci-
nosarcoma from stromal tumor and an important diagnostic
consideration.3
Clinically, carcinosarcomas are characterized by short
doubling time (around 2 months) and rapid growth.1
They are typically large at presentation (mean, 6–7 cm)
and polypoid.2 Oat cell carcinoma, squamous cell carci-
noma, and adenocarcinoma might also present as bulkyFrom the Department of Thoracic Surgery, Departments of Rheumatology and
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The Journal of Thoracic and Capolypoid tumors of the esophagus, although much more
rarely.5 Endoscopic biopsy specimens show only the epi-
thelial component in close to two thirds of cases.2 In spite
of their propensity to cause symptoms earlier because of
their large size and the fact that more than 80% of tumors
are limited to the submucosa or muscularis propria at pre-
sentation,2,4,5 these tumors might behave aggressively, and
thus radical resection in the form of esophagectomy is ad-
vocated.1,2 Local resection through an esophagotomy has
been described in frail patients thought to represent
a high operative risk, with occasional long-term survival.2
Chemotherapy and radiotherapy have rarely been reported,
and their efficacy is unclear.2 Long-term prognosis is
thought to be similar to that of pure squamous cell carci-
noma of the esophagus.5References
1. Hung JJ, Li AF, Liu JS, LinYS, HsuWH.Esophageal Carcinosarcomawith basaloid
squamous cell carcinoma and osteosarcoma. Ann Thorac Surg. 2008;85:1102-04.
2. Iascone C, Barreca M. Carcinosarcoma and pseudosarcoma of the esophagus: two
names, one disease—comprehensive review of the literature. World J Surg. 1999;
23:153-7.
3. Kimura H, Konishi K, Kawamura T, Nojima N, Satou T, Maeda K, et al. Esopha-
geal sarcomas: report of three cases. Dig Surg. 1999;16:244-7.
4. Ziauddin MF, Rodriguez HE, Quiros ED, Connolly MM, Podbielski FJ, et al. Car-
cinosarcoma of the esophagus—pattern of recurrence. Dig Surg. 2001;18:216-8.
5. Olmsted WW, Lichtenstein JE, Hyamus VJ. Polypoid epithelial malignancies of
the esophagus. AJR Am J Roentgenol. 1983;140:921-5.Pulmonary artery ligation with lung preservation in Behcet disease:
Report of a case with prolonged survivalRizwan Attia, MRCS, John Reidy, FRCR, David D’Cruz, FRCP, and Loı¨c Lang-Lazdunski, MD, PhD,
FRCS, London, United KingdomRupture of a pulmonary artery (PA) aneurysm remains
a leading cause of death in patients with Behcet disease.1
We present a case of successful PA ligation and lung preser-vation with prolonged survival in a patient with Behcet
disease and bilateral PA aneurysm.
CLINICAL SUMMARY
A 36-year-old white man with bilateral PA aneurysms and
known Behcet disease had a massive hemoptysis. Medical
history included oral and genital ulcerations, pulmonary em-
bolus, left lower lobe infarction, and iliac vein thrombosis
after cardiotomy for suspected tricuspid valve endocarditis.
The patient was receiving steroids, immunosuppressants,
and warfarin. Five months previously, he had coil emboliza-
tion of an expanding pseudoaneurysm of a basal segmental
branch of the right PA, and a covered stent was placed into
this arterial branch (Figure 1).rdiovascular Surgery c Volume 139, Number 4 e93
